Net Cash Provided by (Used in) Operating Activities |
-116K |
USD |
+72.2% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-5K |
USD |
-100% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
86K |
USD |
|
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
500M |
shares |
|
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
4.22M |
shares |
|
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
178K |
USD |
-72.3% |
Q2 2024 |
Q2 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
-100% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
1.86M |
USD |
+10.5% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Gross |
1.86M |
USD |
+10.5% |
Q4 2023 |
FY 2023 |
Depreciation |
10K |
USD |
+66.7% |
Q1 2023 |
Q1 2023 |
Payments to Acquire Property, Plant, and Equipment |
113K |
USD |
+335% |
Q1 2024 |
Q1 2024 |
Operating Lease, Liability, Current |
15K |
USD |
|
Q3 2022 |
Q3 2022 |
Deferred Tax Assets, Operating Loss Carryforwards |
1.86M |
USD |
+10.5% |
Q4 2023 |
FY 2023 |
Additional Paid in Capital |
20.6M |
USD |
+10.2% |
Q2 2023 |
Q2 2023 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q4 2023 |
FY 2023 |
Share-based Payment Arrangement, Expense |
9K |
USD |
-87.8% |
Q1 2024 |
Q1 2024 |